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Perspectives on Oxygen Sensing Minireview
whether similar or different O2 sensing mechanisms areGregg L. Semenza
Institute of Genetic Medicine utilized when one compares acute and chronic re-
sponses or responses in depolarizable and nondepolar-The Johns Hopkins University
School of Medicine izable cells. Progress in this field has been slow because
of the limitations inherent to the use of pharmacologicBaltimore, Maryland 21287
tools to dissect complex pathways of fundamental phys-
iologic importance, and genetic approaches to the prob-
lem have been lacking.Physiological Perspective
A priori, one could postulate a variety of mechanismsRegardless of whether bacteria, yeast, invertebrates, or
by which cells might measure O2 concentration. In thevertebrates are analyzed, every organism has the ability
simplest model, the sensor binds O2 directly, such thatto sense and respond to reduced O2 availability (hyp-
as O2 concentration declines, the fraction of sensor mol-oxia). As with other physiologic stimuli, a hypoxic stimu-
ecules containing bound ligand declines (Figure 1A).lus/response can be categorized as either acute or
In the bacterium Rhizobium meliloti, a two-componentchronic (Table 1). Acute responses occur over a time
signaling system consists of FixL, a hemoprotein kinasescale of seconds to minutes and involve the posttransla-
that is active in the deoxy state, and FixJ, a transcriptiontional modification of proteins or other macromolecules
factor that is active when phosphorylated by FixL (Gongthrough reduction±oxidation reactions, phosphoryla-
et al., 1998 and references therein). A hemoprotein O2tion±dephosphorylation, etc. Chronic responses occur
sensor was also proposed for mammalian cells (Gold-over a time scale of minutes to hours and involve
berg et al., 1988). There has been no experimental sup-changes in gene expression.
port for a ligand model, but it remains possible thatIn mammals, O2 sensing was originally attributed
mammalian O2 sensing involves molecular interactionssolely to specialized chemoreceptor cells in the carotid
with one or more hemoproteins (see below). Besidesand neuroepithelial bodies that sense O2 concentrations
heme, iron-sulfur clusters represent another intracellularin the bloodstream and airways, respectively, and rap-
target for O2 (Figure 1B). In the presence of O2, ironidly depolarize as a result of hypoxia-induced K1 chan-
regulatory protein 1 is degraded via iron-sulfur clusternel inhibition, resulting in the activation of neural circuits
formation (Iwai et al., 1998). Although preliminary studiesthat lead to alterations in cardiovascular and respiratory
suggested that HIF-1 contained non-heme iron, the re-output, respectively. It is now appreciated that all mam-
sults could not be reproduced (Salceda and Caro, 1998).malian cells can sense changes in O2 concentration. A
HIF-1a is a basic-helix-loop-helix-PAS protein and theuniversal response to reduced O2 availability involves
PAS domain is extensively utilized for O2 and redox sens-the expression of hypoxia-inducible factor 1 (HIF-1), a
ing in Archaea, Bacteria (e.g., FixL), and Eucarya (re-transcriptional activator of genes encoding erythropoie-
viewed by Taylor and Zhulin, 1999), suggesting thattin (EPO), which stimulates red blood cell production,
HIF-1 activity may be directly affected by changes in O2and vascular endothelial growth factor, which stimulates
concentration.angiogenesis, both serving to increase O2 delivery; and
Alternatively, a metabolite of O2 may be sensed. Anglucose transporters and glycolytic enzymes, which fa-
NAD(P)H oxidase could convert O2 to superoxide anioncilitate ATP production in the absence of O2 (reviewed
(O22), which is converted to hydrogen peroxide (H2O2)by Semenza, 1998). This modulation of target gene tran-
by superoxide dismutase (SOD) (Figure 1C). As O2 con-scriptional activity is achieved via O2-dependent regula-
centration declines, this model predicts that the produc-tion of the HIF-1a subunit at multiple levels, including
tion of ROS (O22 and H2O2) declines, thus providing amRNA expression, nuclear localization, transactivation
redox signal for hypoxia (Fandrey et al., 1994; Ehleben etdomain function, and protein stability via modulation of
al., 1998; and references therein). Diphenylene iodoniumubiquitination/proteasomal degradation.
(DPI), an inhibitor of NAD(P)H oxidases (and other flavo-Medical Perspective
proteins) stimulates depolarization of carotid and neuro-Not only does hypoxia represent a fundamental physio-
epithelial bodies, as predicted by the model. However,logic response in all organisms, but hypoxia is also criti-
cal to the pathogenesis of major causes of mortality,
including myocardial ischemia, stroke, cancer, and
Table 1. Examples of Acute and Chronic Responses to Hypoxiachronic lung disease. Although these issues are beyond
the scope of the present discussion, genetic and phar- Acute Chronic
macologic strategies designed to amplify adaptive re-
Increased cardiac output Myocardial hypertrophysponses to hypoxia in ischemic tissues and to inhibit
Systemic arterial Neovascularization
these responses in cancer cells hold great promise as vasodilation
novel and effective therapies for these fatal disorders. Pulmonary arterial Pulmonary vascular remodeling
Biochemical Perspective vasoconstriction
Decreased K1 channel Decreased K1 channelDespite progress in identifying cellular and systemic
activity mRNA/proteinresponses to hypoxia, the precise mechanism(s) by
Increased glycolytic Increased glycolytic enzymewhich O2 concentrations are sensed by multicellular or-
enzyme activity mRNA/protein
ganisms remains undetermined. Indeed it is unknown
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Figure 1. Models of O2 Sensing
(A) The activity of a hemoprotein sensor is
determined by the presence or absence of
bound O2.
(B) The activity of a sensor protein containing
an iron/sulfur-cluster is determined by its oxi-
dation state.
(C) ROS are generated by a membrane-bound
NAD(P)H oxidase in direct proportion to the
O2 concentration, and decreased cytosolic
ROS generation signals hypoxia.
(D) Hypoxia inhibits the activity of cyto-
chrome oxidase (cyt aa3) leading to increased
mitochondrial ROS generation. DPI is an in-
hibitor of flavoproteins, including NAD(P)H
oxidases and ETC complex I, whereas rote-
none is a specific inhibitor of the latter. In
each of these models, O2 or ROS could either
directly interact with effector proteins (such
as a K1 channel or HIF-1) or instead activate
a signal transduction pathway (such as a ki-
nase cascade) leading to effector activation.
DPI inhibits induction of HIF-1 and downstream genes data supporting one or the other model (Chandel et al.,
1998; Ehleben et al., 1998). One interpretation is thatin response to hypoxia (Gleadle et al., 1995), an effect
opposite to that predicted. Thus, the data are most con- different probes are measuring different oxidants which
are generated in response to hypoxia and that thesesistent with involvement of an NAD(P)H oxidase in hyp-
oxia-induced depolarization of chemoreceptor cells, but probes (and the catchword ªROSº) lack sufficient preci-
sion to be useful in resolving this debate. Since conflict-confirmatory genetic data are needed.
An alternative model proposes that mitochondrial ing results have been obtained using the same cell line,
the differences are unlikely to reflect cell type specificity,electron transport chain (ETC) complex IV (cytochrome
c oxidase) plays an important role in O2 sensing. Data although this is not meant to exclude the possibility of
different O2-sensing mechanisms in different cell typessupporting this model have been obtained for both yeast
and human cells (Wilson et al., 1994; Chandel et al., or even within a single cell.
Genetic Perspective1998; Kwast et al., 1999). Under hypoxic conditions the
reduction of O2 to H2O by cytochrome oxidase is inhib- Further progress in this field would be greatly facilitated
by genetic approaches utilizing somatic cells and/orited, resulting in release of electrons upstream at com-
plex III and generation of O22 (Figure 1D). Inhibition of model organisms. This is the first major contribution of
the recent study by Wingrove and O'Farrell (1999) thatcomplex I (by DPI or rotenone) decreases O22 formation
and inhibits induction of HIF-1 and downstream genes utilized Drosophila melanogaster as a model organism
to investigate molecular mechanisms of O2 homeosta-in response to hypoxia, as predicted by the model. In
r0 cells, which lack mitochondrial DNA and ETC activity, sis. The second major contribution is their demonstra-
tion of a role for cGMP-dependent protein kinase (PKG)hypoxia does not induce ROS production or the expres-
sion of HIF-1 or downstream genes. and/or nitric oxide synthase (NOS), using genetic and
pharmacologic approaches in a remarkable spectrumOne might assume that measurement of ROS levels
as a function of O2 concentration would be sufficient to of behavioral, cellular, developmental, and survival re-
sponses to hypoxia in this organism. Their data indicatedistinguish between these latter two models. Unfortu-
nately, direct measurements of ROS are technically de- that both acute and chronic responses to hypoxia are
impaired in flies carrying a mutation in the gene encod-manding and experiments utilizing different probes that
become fluorescent upon oxidation by ROS (dihydrorho- ing PKG or in flies exposed to the NOS inhibitor L-NAME,
and these responses are amplified in transgenic fliesdamine 123, dichlorofluorescin diacetate) have yielded
Minireview
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HIF-1a protein expression and transactivation function
(Huang et al., 1999) possibly via inhibition of ETC com-
plex I. Finally, HIF-1 activates expression of genes en-
coding inducible NOS and heme oxygenase 1 resulting
in the production of NO and CO, respectively (reviewed
by Semenza, 1998). The further characterization and
cloning of mammalian mtNOS and analysis of knockout
mouse ES cells lacking expression of this or other NOS
isoforms (or other components of the guanylate cyclase/
PKG axis) may provide additional insights into mecha-
nisms of O2 sensing.
Whereas flies express only a single NOS isoform,
mammals express three, and possibly four, different iso-
forms, which illustrates a potential limitation of utilizing
invertebrates to understand mammalian biology. This
difference in relative complexity is also observed with
respect to development and physiology. Whereas Dro-Figure 2. A Model for Hypoxia Signal Transduction Pathways in
sophila develop tracheal tubes that allow direct diffusionDrosophila
of O2 to all cells, the greatly increased size of mammalsAlthough both pathways are NOS dependent, one is PKG indepen-
necessitated development of complex circulatory anddent (left) whereas the other is PKG dependent (right). Both path-
ways can be inhibited by either L-NAME or O2. The two models are respiratory systems for O2 delivery. It is likely that hyp-
similar to those proposed for mammalian cells (Figure 1): the PKG- oxia signal transduction in mammals will also be more
independent and -dependent pathways involve cytochrome oxidase complex than in Drosophila. Just as we now appreciate
and NAD(P)H oxidase, respectively. that O2 sensing is not restricted to specialized chemore-
ceptor cell types, the paradigm of a monolithic O2 sensor
responsible for initiating biological responses to hypoxiathat overexpress NOS. These results will stimulate inter-
may represent an oversimplification. Given the funda-est in the use of model organisms to genetically dissect
mental importance of O2 homeostasis for survival, multi-hypoxia signal transduction pathways and will also fo-
ple hypoxia signal-transduction and modulatory cross-cus attention on the role of NO in mammalian O2 sensing. talk pathways may eventually be identified. For now,Can any connections be made between available data
understanding at least one of these pathways remainsfrom Drosophila and mammalian cells? Analysis of iso-
a formidable challenge.lated rat liver mitochondria (Giulivi, 1998) and cultured
endothelial cells (Clementi et al., 1999) revealed that as Selected Reading
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